ADH5 and hepatocellular carcinoma: These studies in part relied on GSNOR knock-out mice that have substantial phenotypic differences when compared to wild type controls, and recent studies from our lab have shown this any purported relationship between genetic deletion of GSNOR and hepatocellular carcinoma is not seen in a haplosufficient model (GRJ and D. Colagiovanni, manuscript in preparation, N30 Pharmaceuticals).